The authors identify HSF1 as a potential therapeutic target but acknowledge that clinical measures for sepsis-induced brain injury remain unavailable. The translational gap between these preclinical findings and clinical application represents a critical barrier to addressing the high mortality burden. Gap type: open_question Source paper: HSF1 Alleviates Brain Injury by Inhibiting NLRP3-Induced Pyroptosis in a Sepsis Model. (2023, Mediators of inflammation, PMID:36741074)
Landscape Summary: How can HSF1-NLRP3 pathway modulation be translated to clinical septic brain injury treatment? is a 0.75 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How can HSF1-NLRP3 pathway modulation be translated to clinical septic brain injury treatment? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: